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Abstract
Background: The occurrence of non-contiguous, multiple, and remote involvement tuberculous spondylitis is rare.
The clinical presentation in patients with multifocal musculoskeletal tuberculosis may closely mimic that in patients
with multiple bone metastases, which makes the accurate clinical diagnosis challenging. Herein, we report a
multifocal musculoskeletal tuberculosis case that was misdiagnosed for 8 months as multiple bone metastases.
Case presentation: A 63-year-old male farmer of Chinese Han ethnicity presented to us with pain in left side of
the neck, right side of the chest and the back for 10 months without typical tuberculosis symptoms. His past
medical history, the CT and fluoroscopy-guided biopsy were negative for tuberculosis. Interferon gamma by T-SPOT
was also negative. Radiological findings including CT, MRI and PET-CT suggested that the patient had multiple
metastases. Accordingly, the patient was misdiagnosed as having musculoskeletal tumors until a swelling under the
right nipple ulcerated. The smear test for acid-fast bacilli and the PCR test for TB-DNA of the pus from the swollen
area were both positive, leading to the final correct diagnosis of musculoskeletal tuberculosis.
Conclusion: The proper diagnosis of musculoskeletal tuberculosis is clinically challenging due to Mycobacterium
tuberculosis variants involved and atypical presentations, especially when the lesions are multiple. Our findings
indicate that multiple tuberculous spondylitis must be considered in the differential diagnosis of multiple
musculoskeletal lesions.
Keywords: Multifocal musculoskeletal tuberculosis, Bone metastases, Atypical presentation
Background
Mycobacterium tuberculosis, the causative agent of tu-
berculosis (TB), is a serious pathogen in many parts of
the world. According to the World Health Organization,
one-third of the world’s population, almost 2 billion
people, is infected with M. tuberculosis [1, 2]. TB is a
concern even in the developed countries; there were
65 TB outbreaks in the United States between 2002 and
2011 that were investigated by the CDC [3]. M. tubercu-
losis usually affects the lungs [4]. In addition, bones and
joints can also be affected (skeletal TB, which accounts
for 5 % of all cases). Among these cases, spines are most
frequently affected and account for almost 50 % of diag-
nosed skeletal TB [5].
In the case of spinal tuberculosis, two or more con-
tiguous vertebrae are usually involved due to
hematogenous spread of bacteria since one vertebral ar-
tery feeds two adjacent vertebrae. As a result, most of
the reported cases of spinal tuberculosis have lesions
that only involve two adjacent levels [6]. According to
reported data, the incidence of multiple-level non-
contiguous vertebral tuberculosis is 1.1 % to 16 % of all
skeletal TB cases [7]. Here, we present a case of multi-
focal musculoskeletal tuberculosis involving multiple
levels of the spine that was misdiagnosed as musculo-
skeletal tumors for 8 months.
Case presentation
A 63-year-old male farmer of Chinese Han ethnicity pre-
sented pain in his left neck, right chest wall and back for
10 months, along with swelling under the right nipple
for 1 month. He was admitted to the hospital on
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November 26, 2014. The left neck pain with no particu-
lar predisposing factors was dull and intermittent in the
beginning. It gradually progressed and extended to the
left upper extremity, where the pain was more serious
and accompanied by numbness at night. The pain even-
tually spread to the chest and back. The patient has no
history of exposure to TB or any recent weight loss,
cough, low-grade fever, decreased appetite or night
sweats.
During the previous 10 months, the patient had been
hospitalized first in the department of orthopedics and
then in the department of interventional radiology. En-
hanced chest computed tomography (CT) studies did
not show any parenchymal lung lesions or lympho-
adenopathy. Then, CT and magnetic resonance imaging
(MRI) both showed multiple osteolytic bone lesions at
C4, C5, C6, T10 and T11 vertebrae, which were noted
along with similar lesions on the ribs of these vertebrae.
The dural sac was pressed at the corresponding surface.
A bone marrow biopsy revealed granulocytosis in the
bone marrow. A fine needle aspiration biopsy of the 9th
rib lesion showed that both bones and cartilages had a
small amount of fibrous tissue attached to them. Ac-
cordingly, multiple bone metastases were suspected
(Fig. 1). Final confirmation of the diagnosis was not
performed, and the patient was discharged from the hos-
pital with a prescription of morphine sustained-release
tablets to relieve the pain. The diagnosis of the patient
could not be confirmed by several hospitals for the fol-
lowing 8 months and no additional biopsies were
performed.
The patient was re-admitted on November 26, 2014 as
the conditions worsened with the development of numb-
ness in both legs. A red swollen area appeared on the
right side of the chest without obvious predisposing fac-
tors 1 month before re-admission. The swelling with ob-
scure boundary and poor mobility grew gradually from
the initial size to about 1 cm × 1 cm at the time of re-
admission.
The vital signs of the patient were stable at the time of
re-admission. No obvious abnormal signs were observed
in neurologic examination. Laboratory results were as
follows: Routine blood test: WBC 11.7 × 109/L, N
75.8 %, RBC 3.06 × 1012/L, HGB 89 g/L, PLT 232 × 109/
L, and serum albumin 38 g/L. Serum protein electro-
phoresis and immune fixation electrophoresis were nor-
mal. The erythrocyte sedimentation rate (ESR) and C-
reactive protein (CRP) level were 60.08 mm/hr (normal
value 0–15 mm/hr) and 37.55 mg/L (normal value 0–
8 mg/L), respectively. Serum tumor markers including
Fig. 1 MRI image of the patient with multifocal musculoskeletal tuberculosis. a MRI showed degeneration in cervical vertebrae. T1-weighted sagittal image
showed heterogeneous, mostly hypointense, lesions involving the C4 and C5 vertebrae (arrowhead). b T2-weighted sagittal image showed posterior
protrusion of C3-4, C4-5, C5-6 and C6-7 and light compression of the corresponding meninges capsule (arrowhead). c MRI showed degeneration of
thoracic vertebra. T1-weighted sagittal image showed heterogeneous, mostly hypointense, lesions involving T11 (arrowhead). d T2-weighted sagittal image
showed posterior protrusion of T11 and light compression of the corresponding meninges (arrowhead)
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AFP, CEA, CA199, CA724 and PSA, were all within nor-
mal ranges. Interferon gamma by T-SPOT was negative.
Hepatitis B surface antigen (HBsAg) and HIV were
negative.
A smear test for acid-fast bacilli of pleural effusion
was negative on November 27, 2014 (CT didn’t show
pleural effusion in April, 2014). A routine pleural effu-
sion test showed: yellow, turbid, WBC: 1500/μl (neutro-
phils 55 %, lymphocytes 45 %), and RBC: 1550/μl.
Rivalta’s test was positive. Pleural effusion biochemical
examination showed: total protein 48.3 g/L, lactate de-
hydrogenase 188 U/L, adenosine deaminase 12.7 U/L,
and glucose 7.08 mmol/L. Malignant cells were not de-
tected in the pleural effusion. 18 F-fluoro-2-deoxy-D-
glucose positron emission tomography (FDG-PET)/com-
puted tomography (CT) revealed that there were mul-
tiple metastases in the bilateral pleural effusion, whole
bone, bilateral hilar lymph nodes, mediastinal lymph
node and chest wall (Fig. 2). But a primary tumor loca-
tion was not detected.
On December 2, 2014, the swelling soft tissue under
the right nipple ulcerated. Both a smear test of acid-fast
bacilli and a polymerase chain reaction (PCR) of TB-
DNA of the pus were positive. As a result, the diagnosis
was corrected to multiple musculoskeletal tuberculosis.
After 1 month of anti-tuberculosis combination therapy
(rifampicin, isoniazid, pyrazinamide and ethambutol),
the swelling significantly decreased and the back pain
was reduced. After 3 months of treatment, the numb-
ness in the arms resolved.
Discussion
Although tuberculosis has drawn great attention, it is
still a major worldwide health burden. The incidence of
musculoskeletal TB appears to be increasing [8, 9]. In
spite of the availability of diagnostic modalities, surgical
techniques and effective anti-tuberculosis regimens,
musculoskeletal tuberculosis (especially spinal tubercu-
losis) remains a life-threatening disease that can cause
bone destruction, deformity and neurological defects
[10]. The case presented here was misdiagnosed as a
musculoskeletal tumor due to the negative results of the
T-SPOT test and the pathological reports, as well as the
abnormal displays in the MRI and PET-CT imaging.
Looking back on this case, we found that several points
should have been considered by the clinicians to facili-
tate the correct diagnosis.
Fig. 2 CT image of the patient with multifocal musculoskeletal tuberculosis. F-18 FDG-PET/CT images showed irregular increased FDG uptake
(arrowheads) with maximum SUVs ranging from 10.2 to 18.5 and involving bilateral collarbones, ribs, thoracolumbar vertebrae, ilium, sacrum,
pubis, hip and the left side of the femoral neck
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First, pain is the main symptom in bone tuberculosis
[10]. Fever and systemic symptoms may not present
until the late stages of musculoskeletal tuberculosis.
Thus, pain may persist long before a definite diagnosis
[11]. So, clinicians should keep in mind the possibility of
musculoskeletal tuberculosis when patients present
long-term musculoskeletal pain even without fever or
any other systemic symptoms.
Second, bone or soft tissue biopsies may be very im-
portant to make a definite diagnosis. However, we
should bear in mind that because of the low bacterial
load in musculoskeletal tuberculosis, the possibility of
detecting Mycobacterium may be less than 50 % [12].
Multiple biopsies should be performed and more time
and attention should be given to microscopy to improve
the rate of correct diagnosis of M. tuberculosis.
Third, a negative T-SPOT result was also a contribut-
ing factor to the delayed diagnosis. Individuals suspected
of having tuberculosis showed a sensitivity of 69–83 %
and specificity of 52–61 % for T-SPOT [13]. T-SPOT
cannot distinguish latent tuberculosis from active tuber-
culosis, and it is not overly specific for active tubercu-
losis [14, 15]. PCR has been recently suggested as an
accurate diagnostic tool since both its sensitivity and
specificity are high, especially for specimens from a ster-
ile area [16].
Forth, as shown in this case, the slightly increased
leukocyte count has a limited value in diagnosis [10]. In-
creasing CRP and ESR serum levels were reported as po-
tential tuberculosis markers in patients with (−) sputum
AFB [17, 18]. CRP was especially emphasized to be a
good marker for indicating a response to the anti-
tuberculosis treatment. Although the specificity of CRP
and ESR are low to diagnose tuberculosis, we should
emphasize their diagnostic value. [17].
Finally, imaging examination is not sensitive for dif-
ferentiating multiple bone metastases from multiple
musculoskeletal tuberculosis. MRI is more sensitive
for the diagnosis of musculoskeletal tuberculosis.
However, when the tuberculosis involves multiple,
non-contiguous vertebrae, the imaging appearance can
be easily misjudged as metastatic malignancy [19].
FDG-PET plays an important role in differentiating
benign from malignant tumors, and in the staging
and follow-up based on the intensity of FDG uptake
[16]. In addition to tumor tissues, the FDG tracer
also accumulates in sites of infection and inflamma-
tion. The active tuberculous lesion sometimes consists
of epithelioid cells, langhans giant cells and lympho-
cytes. As such, cells in the active tuberculous lesion
exhibit increased glucose metabolism and intense
FDG uptake, which can cause misdiagnosis when dif-
ferentiating tuberculosis from malignancy [20]. Since
FDG-PET is not tumor-specific, microbiological and
histopathological examinations may be necessary to
reduce the possibility of image misdiagnosis.
Conclusions
Atypical presentations of multiple musculoskeletal tu-
berculosis pose diagnostic challenges. Mutiple involve-
ment of tuberculous spondylitis must be considered in
the differential diagnosis of multiple musculoskeletal le-
sions. Microbiological and histopathological examination
may be necessary to reduce the possibility of image
misdiagnosis.
Consent
Written informed consent was obtained from the patient
for publication of this case report. A copy of the written
consent is available for review by the Editor of this
journal.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
JH and MY conceived the idea of the case report and coordinated drafting
the manuscript. JW, JR, JT, WY, and TZ participated in the literature review.
All authors have contributed to the draft of the article and have read and
approved the final manuscript.
Acknowledgements
The authors declare that funding was not utilized for the preparation of this
manuscript.
Author details
1Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, China.
2Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Received: 6 August 2015 Accepted: 22 January 2016
References
1. Polley P, Dunn R. Noncontiguous spinal tuberculosis: incidence and
management. Eur Spine J. 2009;18(8):1096–101.
2. Khue PM, Truffot-Pernot C, Texier-Maugein J, Jarlier V, Robert J. A 10-year
prospective surveillance of Mycobacterium tuberculosis drug resistance in
France 1995–2004. Eur Respir J. 2007;30(5):937–44.
3. Haddad MB, Mitruka K, Oeltmann JE, Johns EB, Navin TR. Characteristics of
Tuberculosis Cases that Started Outbreaks in the United States, 2002–2011.
Emerg Infect Dis. 2015;21(3):508.
4. Kanga I, Taylor JA, Jacobs C, Outerbridge G. Tuberculosis of the
neuromusculoskeletal system: a review of two cases presenting as
chiropractic patients. J Can Chiropr Assoc. 2015;59(1):13.
5. Huang B, Li CQ, Liu T, Zhou Y. Primary non-Hodgkin's lymphoma of the
lumbar vertebrae mimicking tuberculous spondylitis: a case report. Arch
Orthop Trauma Surg. 2009;129(12):1621–5.
6. Kim JH, Kim SH, Choi JI, Lim DJ. Atypical noncontiguous multiple spinal
tuberculosis: a case report. Korean J Spine. 2014;11(2):77–80.
7. Kaila R, Malhi AM, Mahmood B, Saifuddin A. The incidence of multiple level
noncontiguous vertebral tuberculosis detected using whole spine MRI. J
Spinal Disord Tech. 2007;20(1):78–81.
8. Abou-Raya S, Abou-Raya A. Spinal tuberculosis: overlooked? J Intern Med.
2006;260(2):160–3.
9. Almeida A. Tuberculosis of the spine and spinal cord. Eur J Radiol. 2005;
55(2):193–201.
10. Mulleman D, Mammou S, Griffoul I, Avimadje A, Goupille P, Valat J-P.
Characteristics of patients with spinal tuberculosis in a French teaching
hospital. Joint Bone Spine. 2006;73(4):424–7.
Ye et al. BMC Infectious Diseases  (2016) 16:34 Page 4 of 5
11. Hammoudeh M, Khanjar I. Skeletal tuberculosis mimicking seronegative
spondyloarthropathy. Rheumatol Int. 2004;24(1):50–2.
12. Luk KD. Tuberculosis of the spine in the new millennium. Eur Spine J. 1999;
8(5):338–45.
13. Metcalfe JZ, Everett CK, Steingart KR, Cattamanchi A, Huang L, Hopewell PC,
et al. Interferon-γ release assays for active pulmonary tuberculosis diagnosis
in adults in low-and middle-income countries: systematic review and meta-
analysis. J Infect Dis. 2011;204 suppl 4:S1120–9.
14. Pai M, Menzies D. Interferon-γ release assays: what is their role in the
diagnosis of active tuberculosis? Clin Infect Dis. 2007;44(1):74–7.
15. Menzies D. Using tests for latent tuberculous infection to diagnose active
tuberculosis: can we eat our cake and have it too? Ann Intern Med. 2008;
148(5):398–9.
16. Park YH, Yu CM, Kim ES, Jung JO, Seo HS, Lee JH, et al. Monitoring
therapeutic response in a case of extrapulmonary tuberculosis by serial F-18
FDG PET/CT. Nucl Med Mol Imaging. 2012;46(1):69–72.
17. Sahin F, Yildiz P. Distinctive biochemical changes in pulmonary tuberculosis
and pneumonia. Arch Med Sci. 2013;9(4):656–61.
18. Peresi E, Silva SMUR, Calvi SA, Marcondes-Machado J. Cytokines and acute
phase serum proteins as markers of inflammatory regression during the
treatment of pulmonary tuberculosis. J Bras Pneumol. 2008;34(11):942–9.
19. Hofmeyr A, Lau WE, Slavin MA. Mycobacterium tuberculosis infection in
patients with cancer, the role of 18-fluorodeoxyglucose positron emission
tomography for diagnosis and monitoring treatment response. Tuberculosis.
2007;87(5):459–63.
20. Metser U, Even-Sapir E. Increased 18 F-fluorodeoxyglucose uptake in
benign, nonphysiologic lesions found on whole-body positron emission
tomography/computed tomography (PET/CT): accumulated data from four
years of experience with PET/CT. In: Seminars in nuclear medicine.
Philadelphia: Elsevier; 2007. p. 206–22.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Ye et al. BMC Infectious Diseases  (2016) 16:34 Page 5 of 5
